Pharmacology For Nurses A Pathophysiologic Approach 5th Edition by Michael Patrick Adams – Test bank

Exam resource for Pharmacology Study Companion 5th Version by Michael Patrick Adams

ISBN 10: 013425516X ISBN-13: 9780134255163

Aid university students in critical thinking like healthcare professionals and grasp the connection between pharmacology and patient care
When medications are viewed separately from the diseases they treat, students may struggle to link pharmacotherapy, pathophysiology, and nursing intervention. Pharmacology for Nurses: A Pathophysiologic Approach, the Fifth Edition, provides a solid foundation for students to understand pharmacology by closely interconnecting it with treatment objectives and patient well-being. With content organized by body systems and related diseases, it contextualizes drugs within therapeutic applications. This integrated approach allows students to readily access information on relevant anatomy, physiology, pathology, and pharmacology within each chapter. The inclusion of Nursing Process Application features explicitly ties pharmacology to essential nursing procedures. Additional highlights cover alternative therapies, community-centered care, evidence-based practices, and considerations across the lifespan to help students build connections to clinical settings. In order to present a comprehensive view of pharmacology’s holistic essence, the Fifth Edition showcases recent advancements in pharmacotherapeutics and disease comprehension.

• Description

• Adams, Pharmacology for Nurses: A Pathophysiologic Approach, 5/E
  Chapter 2

  Question:1

  Item Type: MCSA

  A pharmaceutical consultant visits a doctor’s office and mentions that his company’s pharmaceutical lab is advertising a drug that has not received approval from the Food and Drug Administration (FDA). How should the nurse react?

  1. “Every pharmaceutical lab in the U.S. must obtain FDA approval before marketing any drug.”

  2. “Is this an over-the-counter (OTC) medication? OTC drugs do not require FDA approval.”

  3. “Is your lab private? Only public labs need FDA approval to market a drug.”

  4. “Your pharmaceutical lab needs to engage in educational research as they are exempt from FDA approval requirements.”

  Correct Response: 1

  Rationale 1: All pharmaceutical labs must secure FDA approval before commercializing a drug.

  Rationale 2: Companies manufacturing over-the-counter medications must obtain FDA approval before marketing them.

  Rationale 3: Private labs must obtain FDA approval before marketing a drug.

  Rationale 4: Labs engaged in educational research are still subject to FDA approval before marketing a drug.

  Global Rationale: All pharmaceutical labs, whether private, public, or academic, are required to secure FDA approval before marketing a drug. Private labs must obtain FDA approval before marketing a drug. Labs involved in educational research must obtain FDA approval before marketing a drug. Manufacturers of over-the-counter drugs must obtain FDA approval before marketing them.

  Cognitive Level: Application

  Client Need: Physiological Well-being

  Client Need Subcategory: Pharmacological and Injectable Therapies

  QSEN Practices: V.B.1 Demonstrating efficient use of technologies and standardized practices that support safety and quality.

  AACN Core Competencies: V.4 Understanding legislative and regulatory procedures linked to healthcare delivery.

  NLN Competencies: Quality and Safety: Policies and procedures.

  Nursing/Integrated Concepts: Nursing Procedure: Implementation

  Learning Outcome: 2-2 Recognize the role of the U.S. Food and Drug Administration (FDA) in the drug approval process.

  MNL Learning Outcome: 1.1.1 Application of fundamental principles in pharmacology.

  Page Number: 13

  Question 2

  Item Type: MCSA

  A nurse is employed by the FDA and is involved in clinical research. What is the primary responsibility of the nurse in this phase of the FDA review and approval process?

  1. Conduct assessments on the general population

  2. Conduct assessments on various animal species

  3. Conduct assessments on human cells cultured in laboratory settings

  4. Conduct assessments on human subjects

  Correct Response: 4

  Rationale 1: Conducting assessments on the general population constitutes post-marketing surveillance.

  Rationale 2: Conducting assessments on different animal species is part of the preclinical investigation stage.

  Rationale 3: Conducting assessments on human cells cultured in labs is part of the preclinical investigation stage.

  Rationale 4: Clinical investigation involves conducting assessments on healthy volunteers initially, followed by selected patients with a specific condition.

  Global Rationale: Clinical investigation involves conducting assessments on healthy volunteers initially and later on selected patients with a specific condition. Conducting assessments on human cells cultured in labs is part of the preclinical investigation stage. Post-marketing surveillance entails conducting assessments on the general population. Preclinical investigation includes conducting assessments on various animal species.

  Cognitive Level: Application

  Client Need: Physiological Well-being

  Client Need Subcategory: Pharmacological and Injectable Therapies

  QSEN Practices: V.B.1 Demonstrating efficient use of technologies and standardized practices that support safety and quality.

  AACN Core Competencies: V.4 Understanding legislative and regulatory procedures linked to healthcare delivery.

  NLN Competencies: Quality and Safety: Policies and procedures.

  Nursing/Integrated Concepts: Nursing Procedure: Implementation

  Learning Outcome: 2-5 Identify the nurse’s role in the drug approval process and in upholding safety protocols.

  MNL Learning Outcome: 1.1.1 Application of fundamental principles in pharmacology.